Xpert® BCR-ABL Ultra p190
Xpert® BCR-ABL Ultra p190 – Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with Acute Lymphoblastic Leukemia (ALL).
Xpert® BCR-ABL Ultra p190 is a quantitative test for BCR-ABL minor breakpoint (p190) transcripts that provide high test sensitivity, standardization, and on-demand molecular results.
Based on the innovative GeneXpert® technology, Xpert® BCR-ABL Ultra p190 automates the entire test process including RNA isolation, reverse transcription, and fully-nested real-time PCR of BCR-ABL target gene and ABL reference gene, in one fully automated cartridge.
Features and benefits:
- Ease of use.
- Processing time <2.5 hours.
- Simply add treated blood sample and an off-board reagent to the Xpert cartridge.
- Results aligned to the IS lot-to-lot through secondary standards calibrated to the BCR-ABL WHO panel.
- Sensitive.
- Includes two internal controls.
- 4 mL input volume of whole blood ensures reproducible detection of low-level transcripts.
- High sensitivity and low inter-laboratory variation.
- Clinically demonstrated limit of detection of 0.0065%.
Find out more about Xpert® BCR-ABL Ultra p190 by visiting the following page: Cepheid.com
We are fully committed to being reliable solution and partner,
focused on helping you enhance your healthcare services
Related Products
Latest Articles
Contact Us